According to a new report Global Facial Fat Transfer Market, published by KBV research, The Global Facial Fat Transfer Market size is expected to reach $3.5 billion by 2025, rising at a market growth of 10.4% CAGR during the forecast period. The facial fat transfer market has gained immense market momentum due to its wide range of benefits to the patients.
The Abdomen sub-segment accounted for the largest share in 2018 and is anticipated to be the fastest-growing segment over the forecast period. This is attributable to its high popularity especially in comparison to other donor sites. The Thigh market is anticipated to grow at a CAGR of 10.6% during (2019 - 2025). Additionally, The Flank market would witness a CAGR of 10.6% during (2019 - 2025).
Clinics and surgery centers reported a significant market share in 2018 and are expected to lead the facial fat transfer market in the future. This is due to an increase in the number of clinics and qualified cosmetic and plastic surgeons and extensive consumer preference for the transfer of fat by qualified experts.
North America dominated the market in 2018 due to the availability of enhanced treatment facilities and the increased demand for cosmetic surgery from the expanding millennial and geriatric population. Asia Pacific is projected to see rapid growth of 11.9% during the forecast period. This can be attributed to an aging population, increasing demand for cosmetic surgery, and an increase in disposable income. Additionally, The Europe market is expected to witness a CAGR of 10% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/facial-fat-transfer-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Allergan PLC, Integra LifeSciences Holdings Corporation, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, Ranfac Corporation, Cytori Therapeutics, Inc., Suneva Medical, Inc., Dr. Korman Laboratories Ltd., Scivision Biotech, Inc., and Teoxane Laboratories SA.
By Donor Site
By End Use
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
